Finanzen von Akso Health Group (AHG)AHGAkso Health Group

Evaluating the bottom line, Akso Health Group maintains a gross margin of 8.90%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -20.54%, while the net margin is -18.59%. These profitability ratios, combined with a Return on Equity (ROE) of -68.03%, provide a clear picture of how effectively AHG converts its operational activities into shareholder value.

In the context of the broader market, AHG competes directly with industry leaders such as REAL and LQDT. With a market capitalization of $1.16B, it holds a significant position in the sector. When comparing efficiency, AHG's gross margin of 8.90% stands against REAL's 74.36% and LQDT's 47.19%. Such benchmarking helps identify whether Akso Health Group is trading at a premium or discount relative to its financial performance.

The stock has a forward P/E of 0 and a price-to-sales ratio of 70.608, which are quite high, indicating that the stock may be overvalued based on sales. However, the FCF yield of 7.58% shows some cash generation capability.